TriMaximize on-demand vodcast
Expert panel including Respiratory Nurse Specialist Jo Hamilton, Chief Investigator and Consultant Physician Prof. Richard Russell and GPwER Dr Sanjeev Rana
The expert panel unpack the real-world findings from TriMaximize1, – breaking down the key outcomes from the study and translating them into practical ways to further support your adult asthma patients.
Trimbow pMDI 87/5/9 is indicated for maintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting β₂‐agonist and medium dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year.2,
Talk to us
Request a call or meeting with your local Chiesi representative at a time which suits you.
Order training inhalers
Support your patients with their inhaler technique by ordering placebo training inhalers directly from Chiesi.
Sign up for updates
Want to hear more from Chiesi? Opt-in to receive updates on Chiesi Air products and services.
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Chiesi Limited on 0800 0092329 (UK) or PV.UK@Chiesi.com.